The U.S. military operation targeting Iran-backed Houthi militants in Yemen, launched on March 15, 2025, has incurred costs nearing $1 billion in under three weeks, according to a CNN report dated April 4, 2025. This operation, aimed at curbing Houthi attacks on Red Sea shipping in support of Israel, has utilized advanced munitions, including the AGM-158 JASSM (Joint Air-to-Surface Standoff Missile), JSOW (Joint Standoff Weapon), and Tomahawk cruise missiles, with hundreds of millions of dollars spent on these alone.
The JASSM, a stealthy long-range cruise missile developed by Lockheed Martin, costs approximately $1.2 million per unit, with its extended-range variant (JASSM-ER) priced higher at around $1.5 million, based on historical U.S. Air Force procurement data. JSOWs, GPS-guided glide bombs, are estimated at $700,000 per unit, while Tomahawk missiles, produced by Raytheon, cost about $2 million each, according to 2023 U.S. Navy budget reports. Assuming a conservative estimate of 200 JASSMs, 150 JSOWs, and 100 Tomahawks used, the munitions expenditure alone could range between $545 million and $600 million, aligning with CNN’s reporting of “hundreds of millions” spent on these weapons.
Beyond munitions, the operational costs of this campaign are substantial. The U.S. has deployed naval assets, including destroyers like the USS Mason, and aircraft such as F/A-18s, alongside MQ-9 Reaper drones, two of which were shot down by the Houthis, each valued at $30 million. The cost of operating a destroyer in a combat zone can exceed $2 million per day, factoring in fuel, maintenance, and personnel, according to a 2022 Government Accountability Office report.
With multiple destroyers involved over 20 days, naval operations alone could add $80–$100 million to the tally. Additionally, the deployment of carrier strike groups, such as the USS Harry S. Truman, which supported anti-Houthi operations (as noted in related X posts), incurs daily costs of $6–$7 million, per a 2021 Congressional Budget Office estimate. If the Truman was active for the entire period, this adds another $120–$140 million. Combined with the loss of drones ($60 million for two MQ-9s) and other logistical expenses, the total expenditure aligns with CNN’s $1 billion estimate, potentially even exceeding it when factoring in intelligence, surveillance, and reconnaissance (ISR) support.
The financial efficiency of this operation, however, is highly questionable, as the strategic outcomes have been minimal. A source cited by CNN admitted that despite the billion-dollar expenditure, “they destroyed some sites, but it didn’t affect the Houthis’ ability to operate in the Red Sea or shoot down American drones.” The Houthis have continued their attacks, downing a second MQ-9 Reaper drone and launching missiles and drones at Red Sea targets.
This lack of impact is particularly stark when compared to historical U.S. military campaigns. For instance, the 2011 Libya intervention, which involved similar munitions, cost $1.1 billion over six months but achieved regime change, whereas the Yemen operation has yielded no significant degradation of Houthi capabilities in just three weeks. The cost-benefit ratio is further skewed by the Houthis’ low-cost, asymmetric tactics—using drones and missiles costing tens of thousands of dollars to force the U.S. into billion-dollar responses.
This mirrors findings from a 2016 Reuters report, which noted the Saudi-led coalition’s struggles in Yemen, where high spending on advanced weaponry failed to decisively counter Houthi resilience, a pattern now repeating with U.S. efforts.
From a financial perspective, this operation highlights a broader issue of diminishing returns in modern military engagements against non-state actors. The U.S. has spent approximately $47 million per day in Yemen, with no clear end in sight, as President Trump has stated the campaign will continue until the Houthis cease their attacks—a goal that remains elusive.
The opportunity cost is significant: $1 billion could fund 10,000 hospital beds for a year in the U.S. (at $100,000 per bed annually, per 2023 healthcare data) or procure 500 additional JASSMs for future conflicts. Moreover, the operation risks further escalation, potentially drawing the U.S. into a protracted conflict with Iran, the Houthis’ primary backer, which could drive costs even higher. With the Houthis showing resilience and the Red Sea crisis ongoing, the U.S. faces a strategic and financial dilemma—either double down on spending with uncertain outcomes or pivot to diplomatic solutions, which could mitigate costs but require concessions that may not align with current policy objectives supporting Israel.
